全文获取类型
收费全文 | 2966篇 |
免费 | 177篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 52篇 |
妇产科学 | 24篇 |
基础医学 | 377篇 |
口腔科学 | 31篇 |
临床医学 | 291篇 |
内科学 | 682篇 |
皮肤病学 | 168篇 |
神经病学 | 329篇 |
特种医学 | 125篇 |
外科学 | 372篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 215篇 |
眼科学 | 72篇 |
药学 | 183篇 |
中国医学 | 3篇 |
肿瘤学 | 170篇 |
出版年
2024年 | 2篇 |
2023年 | 28篇 |
2022年 | 21篇 |
2021年 | 103篇 |
2020年 | 87篇 |
2019年 | 114篇 |
2018年 | 107篇 |
2017年 | 81篇 |
2016年 | 91篇 |
2015年 | 91篇 |
2014年 | 131篇 |
2013年 | 191篇 |
2012年 | 263篇 |
2011年 | 254篇 |
2010年 | 136篇 |
2009年 | 110篇 |
2008年 | 178篇 |
2007年 | 181篇 |
2006年 | 185篇 |
2005年 | 181篇 |
2004年 | 149篇 |
2003年 | 119篇 |
2002年 | 106篇 |
2001年 | 17篇 |
2000年 | 12篇 |
1999年 | 5篇 |
1998年 | 5篇 |
1997年 | 12篇 |
1996年 | 17篇 |
1995年 | 21篇 |
1994年 | 12篇 |
1993年 | 14篇 |
1992年 | 8篇 |
1991年 | 14篇 |
1990年 | 5篇 |
1989年 | 14篇 |
1988年 | 9篇 |
1987年 | 4篇 |
1986年 | 5篇 |
1985年 | 5篇 |
1984年 | 5篇 |
1983年 | 6篇 |
1982年 | 14篇 |
1981年 | 9篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1977年 | 3篇 |
1975年 | 2篇 |
1972年 | 2篇 |
排序方式: 共有3145条查询结果,搜索用时 15 毫秒
1.
Andreas Glenthj Lasse H. Jakobsen Henrik Sengelv Syed A. Ahmad Kristian Qvist Annika Rewes Christian B. Poulsen Ulrik M. Overgaard Ingolf Mlle Marianne T. Severinsen Casper N. Strandholdt Jack Maibom Annette R. Kodahl Jesper Ryg Pernille Ravn Isik S. Johansen Sren N. Hels Sren Jensen‐Fangel Jacek Kisielewicz Lothar Wiese Marie Helleberg Ole Kirk Michael R. Clausen Henrik Frederiksen 《European journal of haematology》2021,106(1):72-81
2.
3.
Paulina Marta Gajda Niels Bjerre Holm Lars Jakobsen Hoej Brian Schou Rasmussen Petur Weihe Dalsgaard Lotte Ask Reitzel Kristian Linnet 《Drug testing and analysis》2019,11(2):350-354
A number of unknown pharmaceutical preparations seized by Danish customs authorities were submitted for liquid chromatography–high resolution mass spectrometry (LC–HRMS) analysis. Comparison with reference standards unequivocally identified the content of the powders as analogs of the growth hormone secretagogues GHRP‐2 (Pralmorelin), GHRP‐6, Ipamorelin, and modified growth hormone releasing factor (modified GRF 1–29), which can be used as performance‐enhancing substances in sports. In all cases, the detected modification involved the addition of an extra glycine amino acid at the N‐terminus, and analytical methods targeting growth hormone secretagogues should hence be updated accordingly. 相似文献
4.
Christian Bredgaard Jensen Anders Troelsen Christian Skovgaard Nielsen Niels Kristian Stahl Otte Henrik Husted Kirill Gromov 《Acta orthopaedica》2020,91(4):433
Background and purpose — Previous studies have investigated risk factors related to prolonged length of stay following total knee arthroplasty (TKA), but little is known about specific factors resulting in continued hospitalization within the 1st postoperative days after unicompartmental knee arthroplasty (UKA). We investigated what specific factors prevent patients from being discharged on the day of surgery (DOS) and the first postoperative day (POD-1) following primary UKA in a fast-track setting.Patients and methods — We prospectively collected data on 100 consecutive and unselected medial UKA patients operated from December 2017 to May 2019. All patients were operated in a standardized fast-track setup with functional discharge criteria continuously evaluated from DOS and until discharge.Results — Median length of stay for the entire cohort was 1 day. 22% and 78% of all patients were discharged on DOS and POD-1, respectively. Lack of mobilization and pain separately delayed discharge in respectively 78% and 24% of patients on DOS. The main reasons for lack of mobilization were motor blockade (37%) and logistical factors (26%). For patients placed 1st or 2nd on the operating list, we estimate that the same-day discharge rate would increase to 55% and 40% respectively, assuming that pain and mobilization were successfully managed.Interpretation — One-fifth of unselected UKA patients operated in a standardized fast-track setup were discharged on DOS. Pain and lack of mobilization were the major reasons for continued hospitalization within the initial postoperative 24–48 hours. Strategies aimed at decreasing length of stay after UKA should strive to improve analgesia and postoperative mobilization.The number of unicompartmental knee arthroplasties (UKAs) performed in patients suffering from osteoarthritis has steadily increased. UKA has the potential benefit of not only improving patient-reported outcomes, but also to reduce morbidity, complications, and cost (Liddle et al. 2014, Beard et al. 2019). In the United Kingdom, 9% of all primary knee arthroplasties performed in 2018 were UKAs while this number is as high as 20% in Denmark (Danish Knee Arthroplasty Register 2019, National Joint Registry for England 2019).UKA is effective and safe when performed in a fast-track setting and outpatient UKA in selected patients has been shown to be feasible and safe (Munk et al. 2012, Cross and Berger 2014, Bovonratwet et al. 2017, Kort et al. 2017). However, the number of patients actually being discharged on DOS that were scheduled for outpatient surgery differs between studies and ranges from 37% to 100% (Gondusky et al. 2014, Bradley et al. 2017, Jenkins et al. 2019, Rytter et al. 2019).Studies have shown an association between increased length of stay (LOS) and an increase in both complication and readmission rates (Otero et al. 2016). In order to reduce LOS and increase patient satisfaction, a focus on successfully managing well-defined discharge criteria in a multimodal approach is imperative (Husted et al. 2008, Cross and Berger 2014). In addition, decreased LOS and outpatient procedures are associated with financial benefits, which have further fueled interest in decreasing LOS and ensuring DOS discharged following UKA (Bradley et al. 2017). Finally, decreased LOS is also shown to increase patient satisfaction levels (Reilly et al. 2005, Richter and Diduch 2017).A study has been conducted to explore reasons for prolonged hospitalization in a fast-track setting following TKA (Husted et al. 2011). However, in spite of a growing number of UKAs performed each year, no study explicitly exploring reasons for prolonged hospitalization beyond DOS following UKA in a fast-track setting has been published at present.Therefore, we investigated reasons for continued hospitalization beyond DOS following UKA in a fast-track setting. 相似文献
5.
Low myocardial glucose uptake in Turner syndrome is unaffected by growth hormone: a randomized,placebo‐controlled FDG‐PET study 下载免费PDF全文
6.
7.
8.
9.
10.